Palo Alto, CA, United States of America

Thomas W Chalberg

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas W Chalberg: Innovator in Osteoarthritis Treatment

Introduction

Thomas W Chalberg is a notable inventor based in Palo Alto, CA. He has made significant contributions to the field of medicine, particularly in the treatment of osteoarthritis. His innovative approach has led to the development of methods that aim to alleviate the suffering of individuals affected by this condition.

Latest Patents

Chalberg holds a patent for "Methods and compositions for treating osteoarthritis." This patent outlines methods for treating a human suffering from osteoarthritis by intra-articularly administering a dosage that includes a nucleic acid coding sequence for a human interleukin-1 receptor antagonist (IL-1Ra). The patent also includes compositions that can be utilized in practicing these methods. He has 1 patent to his name.

Career Highlights

Throughout his career, Chalberg has worked with prominent organizations such as Genascence Corporation and the Mayo Foundation for Medical Education and Research. His work in these institutions has allowed him to further his research and develop innovative solutions for osteoarthritis treatment.

Collaborations

Chalberg has collaborated with notable individuals in his field, including Christopher Howard Evans and Ian J Constable. These collaborations have contributed to the advancement of his research and the development of effective treatment methods.

Conclusion

Thomas W Chalberg is a distinguished inventor whose work in osteoarthritis treatment has the potential to improve the quality of life for many individuals. His innovative methods and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…